+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Branched chain enriched amino acid solutions in the treatment of hepatic encephalopathy a controlled trial

Branched chain enriched amino acid solutions in the treatment of hepatic encephalopathy a controlled trial

Italian Journal of Gastroenterology 17(1): 5-10

The efficacy of a specially formulated amino acid (AA) mixture was compared to that of lactulose in a prospective randomized trial performed on 48 cirrhotics patients with hepatic encephalopathy (HE). The patients were randomly assigned to one of the following 3 different therapeutic protocols: group A: lactulose + hypertonic glucose; group B: special AA mixture (Trade name BS666) + hypertonic glucose; group C: lactulose as in group A + BS666 as in group B. In terms of patient awakening, BS666 is more efficacious than lactulose which was, nevertheless, efficacious in reversing HE in 62.3% of patients in group A. The best results were observed following the combined use of lactulose and BS666 (gorup C: 100% of patients awoke by the end of treatment) and thus a cumulative effect of the 2 therapeutic measures might be suggested. The BCAA/AAA plasma ratio which was statistically higher in groups B and C with respect to baseline values, appeared to be well correlated with the clinical-neurological evolution of HE. Blood ammonia resulted significantly decreased in these same groups thus suggesting that the BCAA rich mixture employed may also act beneficially on HE through decreasing this "toxic" substance. The decrease, although not statistically significant, in octopamine plasma levels seems to confirm that false neurotransmitters can be somehow involved in the pathogenesis of HE.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 004857609

Download citation: RISBibTeXText

Related references

Treatment of hepatic encephalopathy with branched chain amino acid enriched solutions a review of randomized controlled trials. Adibi, S A Et Al (Ed ) Branched Chain Amino And Keto Acids in Health And Disease; International Symposium, Goettingen, West Germany, Oct 21-23, 1983 Xiv+571p S Karger: Basel, Switzerland; New York, N Y , Usa Illus 497-504, 1984

Pharmacological studies of branched chain amino acid and arginine enriched amino acid solution mhs 2 for the treatment of hepatic encephalopathy effect on the ammonia metabolism in pca rats. Japanese Journal of Pharmacology 52(Suppl. 1): 336P, 1990

Comparison of dietary protein with an oral, branched chain-enriched amino acid supplement in chronic portal-systemic encephalopathy: a randomized controlled trial. Hepatology 4(2): 279-287, 1984

Treatment of acute hepatic encephalopathy in cirrhotics with a branched-chain amino acids enriched versus a conventional amino acids mixture. A controlled study of 70 patients. Liver 5(5): 282-289, 1985

Long-term oral branched-chain amino acid treatment in chronic hepatic encephalopathy. A randomized double-blind casein-controlled trial. The Italian Multicenter Study Group. Journal of Hepatology 11(1): 92, 1990

Branched chain enriched amino acid versus glucose treatment of hepatic encephalopathy. A double-blind study of 65 patients with cirrhosis. Journal of Hepatology 10(3): 291-296, 1990

Effect of branched chain amino acid enriched amino acid solution on normalization of plasma amino acids in hepatic encephalopathy. Taiwan yixuehui zazhi 84(3): 331-338, 1985

Infusion of branched-chain enriched amino acid solution in patients with hepatic encephalopathy. Annals of Surgery 196(2): 209-220, 1982

Intra venous branched chain amino acid infusions vs. lactulose in the treatment of hepatic encephalopathy a controlled study. Gastroenterology 82(5 Part 2): 1226, 1982

Valine enriched branched-chain amino acids in the treatment of hepatic encephalopathy. Zeitschrift fuer Gastroenterologie 31(4): 235-241, 1993

Effects of a branched-chain amino acid-enriched diet on chronic hepatic encephalopathy in dogs. Metabolic Brain Disease 14(2): 103-115, 1999

Chronic hepatic encephalopathy. Long-term therapy with a branched-chain amino-acid-enriched elemental diet. JAMA 242(4): 347-349, 1979

Long term therapy of chronic hepatic encephalopathy and protein intolerance with a branched chain enriched amino acid elemental diet. Gastroenterology 76(5 Part 2): 1281, 1979

Branched chain amino acid-enriched solutions in the septic patient. A randomized, prospective trial. Annals of Surgery 203(1): 13-20, 1986

Solutions of selective and branched-chain amino acids in the treatment of hepatic encephalopathy in cancer patients. La Clinica Terapeutica 108(4): 313-318, 1984